📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Effects of tranexamic acid treatment in severely and non-severely injured trauma patients. (2022)

First Author: Ageron FX

Attributed to: The CRASH-3 Trial: Tranexamic acid for the treatment of significant traumatic brain injury. funded by GCRF

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/trf.16954

PubMed Identifier: 35748686

Publication URI: http://europepmc.org/abstract/MED/35748686

Type: Journal Article/Review

Volume: 62 Suppl 1

Parent Publication: Transfusion

Issue: Suppl 1

ISSN: 0041-1132